Then we analyzed the mRNA levels of stemness-related markers in IL25 treated HT-29 and SW620 cells, which showed that expression of stemness-related markers, especially, CD133, LGR5, and OCT-4 were elevated in IL25 treated CRC cells (Figure 3A and Figure S3G). The gene discussed is IL25; the disease is colorectal carcinoma.